Market Overview

UPDATE: ISI Group Initiates Market Weight, $45 PT on Illumina on Soft Demand Environment

Related ILMN
The 4 Companies Teaming Up For A New Tool To Fight Cancer
US Stock Futures Surge Ahead Of Economic Data
Related ILMN
Markets Mostly Higher Despite Initial Negative Reaction From FOMC Minutes
Wedbush Upgrades Illumina To Outperform, Shares Rise

ISI Group initiated its coverage on Illumina (NASDAQ: ILMN) with a Market Weight rating and a $45 price target.

ISI Group noted, "We are initiating coverage on shares of Illumina with a Market Weight rating and a price target of $45.00, which on a forward basis equates to ~12x EV/EBITDA and ~25x operating EPS. Our thesis for ILMN is based on our view that strong growth in MiSeq and an improving HiSeq through-put will help to offset an increasingly challenging budgetary environment, that microarray growth will remain modest as demand for emerging applications helps to soften a slowdown in legacy GWAS, and that recent strategic interest in asset (e.g. Roche's hostile bid) provides a modest valuation premium."

Illumina closed at $40.60 on Monday.

Latest Ratings for ILMN

DateFirmActionFromTo
Sep 2014Morgan StanleyInitiates Coverage onEqual-weight
Aug 2014WedbushUpgradesNeutralOutperform
Aug 2014Stifel NicolausInitiates Coverage onBuy

View More Analyst Ratings for ILMN
View the Latest Analyst Ratings

Posted-In: ISI GroupAnalyst Color Price Target Initiation Pre-Market Outlook Analyst Ratings

 

Related Articles (ILMN)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters